Edition:
United Kingdom

NuCana PLC (NCNA.OQ)

NCNA.OQ on NASDAQ Stock Exchange Global Select Market

11.00USD
15 Dec 2017
Change (% chg)

$0.32 (+3.00%)
Prev Close
$10.68
Open
$10.75
Day's High
$11.60
Day's Low
$10.66
Volume
49,538
Avg. Vol
--
52-wk High
$19.95
52-wk Low
$9.71

Chart for

About

NuCana PLC is a clinical-stage biopharmaceutical company. The Company is focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The Company utilizes its ProTide technology to develop medicines to overcome cancer resistance mechanisms and generate much higher concentratio... (more)

Overall

Beta: --
Market Cap(Mil.): $522.83
Shares Outstanding(Mil.): 30.88
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

Earnings vs. Estimates